Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
SAGE Open Med Case Rep ; 12: 2050313X241261019, 2024.
Article in English | MEDLINE | ID: mdl-38881979

ABSTRACT

We report the case of a patient who exhibits a concurrent diagnosis of type 1 diabetes mellitus, Gitelman syndrome and Cacci-Ricci disease. A 27-year-old male patient was diagnosed with Gitelman syndrome at the age of 3 years. Fourteen years later, he developed an autoantibody-negative type 1 diabetes mellitus. Cacci-Ricci's disease was revealed by terminal hematuria and considered in view of the appearance found on the computed tomography (CT) scan. The finger-prick blood glucose level was 6 g/dl with no acetonuria. Creatinine clearance was 60 ml/min. Thyroid function tests were normal. Calcium, phosphorus and parathormone (PTH) levels were normal. Discussion: Gitelman syndrome is a rare disorder. The association between Gitelman syndrome and type 1 diabetes mellitus has been reported in the literature in two patients. Authors have investigated the association between Gitelman syndrome and type 2 diabetes mellitus. Several pathophysiological explanations have been put forward. Cacci-ricci disease is a rare, benign congenital anomaly. No association between type 1 diabetes mellitus, Gitelman syndrome and Cacci-Ricci disease has been reported in the literature. To our knowledge, this is the first case described in the literature.

2.
Gynecol Endocrinol ; 37(9): 863-866, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34124989

ABSTRACT

AIMS AND METHODS: Prolactinomas are a common cause of sexual dysfunction and infertility. We aimed, through this case report, to illustrate the difficulties of management of women with giant prolactinoma, especially in cases of desire of pregnancy. RESULTS: A 30-year-old woman was referred to our department for secondary amenorrhea. Investigations showed a prolactin level of 5168 ng/mL and giant pituitary adenoma of 4 cm in diameter. Cytoreductive surgery was performed after failure to normalize prolactin levels during three years with medical treatment by cabergoline. After seven months, menstrual cycles have resumed, and after 13 months, the patient became pregnant. At 22nd week of gestation, she was admitted in our hospital for pituitary apoplexy. Medical treatment with bromocriptine was chosen. The vaginal premature delivery at 28 weeks gave birth to twins weighing 1 Kg each who died on the 7th day of life. CONCLUSION: This is a relevant clinical case that illustrates the efficacy of cytoreductive surgery in case of insufficient response to dopamine agonists to restore gonadal function. The possibility of a pregnancy should be considered in these patients since it can be associated with high maternal and fetal risks.


Subject(s)
Pituitary Apoplexy/complications , Pituitary Neoplasms/complications , Pregnancy Complications, Neoplastic/physiopathology , Pregnancy, Twin , Prolactinoma/complications , Adult , Cabergoline/therapeutic use , Cytoreduction Surgical Procedures , Fatal Outcome , Female , Humans , Infertility/etiology , Magnetic Resonance Imaging , Pituitary Apoplexy/diagnosis , Pituitary Apoplexy/physiopathology , Pituitary Neoplasms/pathology , Pituitary Neoplasms/therapy , Pregnancy , Pregnancy Complications, Neoplastic/diagnosis , Pregnancy Complications, Neoplastic/pathology , Premature Birth , Prolactin/blood , Prolactinoma/pathology , Prolactinoma/therapy
3.
Clin Case Rep ; 9(3): 1655-1662, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33768909

ABSTRACT

The presence of prostatic tissue, in addition to uterus and adrenal tumors, is possible in 46XX patients with CAH. Lesions of these organs are usually benign. However, complications including prostate and adrenal cancer were also reported.

4.
Pan Afr Med J ; 36: 226, 2020.
Article in English | MEDLINE | ID: mdl-33708317

ABSTRACT

Congenital adrenal hyperplasia refers to a group of rare genetic disorders affecting the adrenal glands. 21-hydroxylase deficiency is the most prevalent and the most studied cause while the remaining enzymatic defects are less common, accounting for less than 10% of cases. We herein described the clinical, biological and molecular characteristics and outcome of patients of the same family diagnosed with 11-Beta-hydroxylase deficiency. The disorder was revealed by peripheral precocious puberty between the age of 2-3 years in males and by the virilization of the external genitalia in females. Genetics finding a homozygous p.Gly379Val mutation in the CYP11B1 gene. All patients received hydrocortisone supplementation therapy and mineralocorticoid-receptor antagonist. The females underwent a surgical correction of the ambiguous genitalia at the neonatal age. Long term follow-up revealed metabolic syndrome, obesity and hypertension in the first two patients, an impaired final height in the two females and hypokalemia in three patients.


Subject(s)
Adrenal Hyperplasia, Congenital/diagnosis , Steroid 11-beta-Hydroxylase/genetics , Adrenal Hyperplasia, Congenital/genetics , Adrenal Hyperplasia, Congenital/physiopathology , Adult , Child , Female , Follow-Up Studies , Humans , Hydrocortisone/administration & dosage , Male , Mineralocorticoid Receptor Antagonists/administration & dosage , Mutation , Puberty, Precocious/etiology , Tunisia
5.
Iran J Allergy Asthma Immunol ; 18(5): 572-583, 2019 Oct 23.
Article in English | MEDLINE | ID: mdl-32245301

ABSTRACT

Insulin therapy is an essential treatment for type 1 and uncontrolled type 2 diabetes mellitus (DM). Hypersensitivity reactions have been described since the first administration of insulin, the same as any other therapy. Despite being a rare situation nowadays, it requires careful intra-hospital monitoring and multidisciplinary management. Here, we present a case of a 57-year-old patient with type 2 DM, an average glycemic control, and both penicillin and insulin allergy. Heunderwent a desensitization protocol which allowed successfully dismiss him with intermediate-acting insulin.


Subject(s)
Drug Hypersensitivity/drug therapy , Drug Hypersensitivity/etiology , Hypoglycemic Agents/adverse effects , Insulin/adverse effects , Desensitization, Immunologic/methods , Diabetes Mellitus, Type 2/drug therapy , Humans , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...